2025 ICD-10-CM code E88.42
(Active) Effective Date: N/A Endocrine, Nutritional and Metabolic Diseases - Metabolic disorders 4 Feed
MERRF (Myoclonic Epilepsy with Ragged Red Fibers) syndrome is a rare mitochondrial disease characterized by myoclonus epilepsy associated with ragged-red fibers in muscle tissue.
The medical necessity for services related to MERRF syndrome is established by the presence of symptoms and a confirmed diagnosis.Genetic testing and muscle biopsy are medically necessary for confirming the diagnosis.Treatment for seizures, ataxia, muscle weakness, and other symptoms is medically necessary to improve or maintain the patient's functional status and quality of life. Ongoing monitoring and supportive care are medically necessary to manage the chronic and progressive nature of the disease.
Diagnosis and management of MERRF syndrome often involve a multidisciplinary team of specialists, including neurologists, geneticists, cardiologists, and rehabilitation therapists. Neurologists typically lead the management of seizures and other neurological symptoms.Clinical geneticists confirm the diagnosis through genetic testing and provide counseling to patients and families. Cardiologists address cardiac complications. Rehabilitation therapists, such as physical and occupational therapists, play a role in improving muscle strength, coordination, and daily functioning.Supportive care and symptom management are crucial components of care for MERRF patients.
In simple words: MERRF syndrome is a rare genetic disorder that affects how the body produces energy. This leads to various problems, especially with muscles and the brain.People with MERRF might have muscle twitches, seizures, trouble with balance and coordination, muscle weakness, and difficulty thinking.Other problems like vision and hearing loss or heart problems might also happen. While there's no cure, treatments can help manage the symptoms.
MERRF syndrome, or Myoclonic Epilepsy with Ragged Red Fibers, is a rare inherited mitochondrial disorder. This condition is caused by mutations in mitochondrial DNA, which disrupt energy production within cells and primarily affect tissues with high energy demands like the brain and muscles.Symptoms typically emerge in childhood or adolescence, but onset can vary. Common clinical manifestations include myoclonus (brief, involuntary muscle jerks), seizures, ataxia (loss of coordination), muscle weakness, and dementia. Other associated features may include hearing loss, vision impairment, cardiomyopathy, peripheral neuropathy, and lipomas. Diagnosis often involves a combination of clinical evaluation, genetic testing, laboratory tests (such as lactate and pyruvate levels), and muscle biopsy which may reveal the characteristic "ragged red fibers." Currently, there is no cure for MERRF syndrome. Treatment focuses on managing symptoms and may include anticonvulsant medications for seizures, supportive therapies like physical therapy, and nutritional interventions to address metabolic deficiencies.
Example 1: A 15-year-old presents with a history of progressive myoclonus, generalized tonic-clonic seizures, and difficulty with balance.A muscle biopsy shows ragged red fibers, and genetic testing confirms a mitochondrial DNA mutation consistent with MERRF syndrome., A young adult with diagnosed MERRF syndrome experiences worsening ataxia and muscle weakness, requiring the use of assistive devices for mobility., A child with MERRF syndrome develops sensorineural hearing loss and is referred to an audiologist for evaluation and management.
Documentation for MERRF syndrome should include a detailed history of the patient's symptoms, including the onset and progression of myoclonus, seizures, ataxia, muscle weakness, and any other neurological or systemic manifestations.Results of genetic testing, muscle biopsy findings, laboratory tests (e.g., lactate, pyruvate), imaging studies (e.g., MRI of the brain), and other diagnostic evaluations should be documented.Details of treatment plans, including medications, therapies, and any assistive devices prescribed, should be included. Regular assessments of the patient's neurological status, functional abilities, and response to treatment should be documented over time.
- Specialties:Neurology, Genetics, Cardiology, Rehabilitation Medicine
- Place of Service:Inpatient Hospital, Outpatient Hospital, Office